907 related articles for article (PubMed ID: 30069427)
21. Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients.
Rieger J; Bähr O; Müller K; Franz K; Steinbach J; Hattingen E
J Neurooncol; 2010 Aug; 99(1):49-56. PubMed ID: 20035366
[TBL] [Abstract][Full Text] [Related]
22. Distinguishing Tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI.
Feng A; Yuan P; Huang T; Li L; Lyu J
Acad Radiol; 2022 Sep; 29(9):1320-1331. PubMed ID: 34896001
[TBL] [Abstract][Full Text] [Related]
23. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
Choi YS; Ahn SS; Lee SK; Chang JH; Kang SG; Kim SH; Zhou J
Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of recurrent high-grade gliomas treated with bevacizumab: A preliminary report of 3D pseudocontinuous artery spin labeling.
Lyu Y; Liu S; You H; Hou B; Wang Y; Ma W; Feng F
J Magn Reson Imaging; 2017 Aug; 46(2):565-573. PubMed ID: 27902863
[TBL] [Abstract][Full Text] [Related]
25. Perfusion MRI as the predictive/prognostic and pharmacodynamic biomarkers in recurrent malignant glioma treated with bevacizumab: a systematic review and a time-to-event meta-analysis.
Choi SH; Jung SC; Kim KW; Lee JY; Choi Y; Park SH; Kim HS
J Neurooncol; 2016 Jun; 128(2):185-94. PubMed ID: 27108275
[TBL] [Abstract][Full Text] [Related]
26. Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.
Verburg N; Koopman T; Yaqub MM; Hoekstra OS; Lammertsma AA; Barkhof F; Pouwels PJW; Reijneveld JC; Heimans JJ; Rozemuller AJM; Bruynzeel AME; Lagerwaard F; Vandertop WP; Boellaard R; Wesseling P; de Witt Hamer PC
Neuro Oncol; 2020 Mar; 22(3):412-422. PubMed ID: 31550353
[TBL] [Abstract][Full Text] [Related]
27. Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring.
Chaumeil MM; Radoul M; Najac C; Eriksson P; Viswanath P; Blough MD; Chesnelong C; Luchman HA; Cairncross JG; Ronen SM
Neuroimage Clin; 2016; 12():180-9. PubMed ID: 27437179
[TBL] [Abstract][Full Text] [Related]
28. Non-invasive assessment of heterogeneity of gliomas using diffusion and perfusion MRI: correlation with spatially co-registered PET.
Zhang Y; Lin Y; Xing Z; Yao S; Cao D; Miao WB
Acta Radiol; 2022 May; 63(5):664-671. PubMed ID: 33858207
[TBL] [Abstract][Full Text] [Related]
29. Mapping glioma heterogeneity using multiparametric 18 F-choline PET/MRI in childhood and teenage-young adults.
Ferrazzoli V; Shankar A; Cockle JV; Tang C; Al-Khayfawee A; Bomanji J; Fraioli F; Hyare H
Nucl Med Commun; 2023 Jan; 44(1):91-99. PubMed ID: 36378239
[TBL] [Abstract][Full Text] [Related]
30. FAP-specific PET signaling shows a moderately positive correlation with relative CBV and no correlation with ADC in 13 IDH wildtype glioblastomas.
Röhrich M; Floca R; Loi L; Adeberg S; Windisch P; Giesel FL; Kratochwil C; Flechsig P; Rathke H; Lindner T; Loktev A; Schlemmer HP; Haberkorn U; Paech D
Eur J Radiol; 2020 Jun; 127():109021. PubMed ID: 32344293
[TBL] [Abstract][Full Text] [Related]
31. ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma.
Nowosielski M; Recheis W; Goebel G; Güler O; Tinkhauser G; Kostron H; Schocke M; Gotwald T; Stockhammer G; Hutterer M
Neuroradiology; 2011 Apr; 53(4):291-302. PubMed ID: 21125399
[TBL] [Abstract][Full Text] [Related]
32. Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma.
Schmainda KM; Prah M; Connelly J; Rand SD; Hoffman RG; Mueller W; Malkin MG
Neuro Oncol; 2014 Jun; 16(6):880-8. PubMed ID: 24431219
[TBL] [Abstract][Full Text] [Related]
33. Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastoma.
Kickingereder P; Wiestler B; Burth S; Wick A; Nowosielski M; Heiland S; Schlemmer HP; Wick W; Bendszus M; Radbruch A
Neuro Oncol; 2015 Aug; 17(8):1139-47. PubMed ID: 25754089
[TBL] [Abstract][Full Text] [Related]
34. Imaging biomarker dynamics in an intracranial murine glioma study of radiation and antiangiogenic therapy.
Chung C; Jalali S; Foltz W; Burrell K; Wildgoose P; Lindsay P; Graves C; Camphausen K; Milosevic M; Jaffray D; Zadeh G; Ménard C
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):805-12. PubMed ID: 22929856
[TBL] [Abstract][Full Text] [Related]
35. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.
Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS
Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
37. DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model.
Hoff BA; Bhojani MS; Rudge J; Chenevert TL; Meyer CR; Galbán S; Johnson TD; Leopold JS; Rehemtulla A; Ross BD; Galbán CJ
NMR Biomed; 2012 Jul; 25(7):935-42. PubMed ID: 22190279
[TBL] [Abstract][Full Text] [Related]
38. Perfusion MRI grading diffuse gliomas: Impact of permeability parameters on molecular biomarkers and survival.
Hilario A; Hernandez-Lain A; Sepulveda JM; Lagares A; Perez-Nuñez A; Ramos A
Neurocirugia (Astur : Engl Ed); 2019; 30(1):11-18. PubMed ID: 30143443
[TBL] [Abstract][Full Text] [Related]
39. Utility of intravoxel incoherent motion magnetic resonance imaging and arterial spin labeling for recurrent glioma after bevacizumab treatment.
Miyoshi F; Shinohara Y; Kambe A; Kuya K; Murakami A; Kurosaki M; Ogawa T
Acta Radiol; 2018 Nov; 59(11):1372-1379. PubMed ID: 29471670
[TBL] [Abstract][Full Text] [Related]
40. Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imaging.
Xiao HF; Chen ZY; Lou X; Wang YL; Gui QP; Wang Y; Shi KN; Zhou ZY; Zheng DD; Wang DJ; Ma L
Eur Radiol; 2015 Dec; 25(12):3423-30. PubMed ID: 26002128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
